Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Seroprevalence of Hbv, Hcv and Hiv Infection Among Intravenous Drug Users in Shahr-E-Kord, Islamic Republic of Iran Pubmed



Imani R1 ; Karimi A2 ; Rouzbahani R3 ; Rouzbahani A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Infectious Diseases, Faculty of Medicine, Shahr-e-Kord University of Medical Sciences, Shahr-e-Kord, Iran
  2. 2. Department of Microbiology and Immunology, Faculty of Medicine, Shahr-e-Kord University of Medical Sciences, Shahr-e-Kord, Iran
  3. 3. Department of Socio-Preventive Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Eastern Mediterranean Health Journal Published:2008


Abstract

This study was conducted in 2004 to evaluate the prevalence of hepatitis B (HBV), hepatitis C (HBC) and human immunodeficiency (HIV) virus infection in 133 injecting drug users (IDUs) attending a voluntary rehabilitation centre in Shahr-e-Kord, and to identify risk factors for these infections in this group. Serum samples were screened for HBV, HCV and HIV infection. Only 1 participant (0.8%) was HIV positive, 15 (11.2%) were HCV positive and 8 (6.0%) were positive for HBV surface antigen. There was significant correlation between using shared syringes and infection with HIV, HCV and HBV.
Related Docs
View other Related Docs
1. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)
2. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)
3. Co-Infection of Human Immunodeficiency Virus, Hepatitis C and Hepatitis B Virus Among Injection Drug Users in Drop in Centers, Journal of Research in Medical Sciences (2014)
4. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002), Hepatitis Monthly (2008)
5. The Prevalence of Hepatitis B, Hepatitis C and Associated Risk Factors in Intravenous Drug Addicts (Ivda) With Hiv in Isfahan, Journal of Isfahan Medical School (2008)
6. Seroprevalence of Hepatitis B Infection and Associated Risk Factors Among Drug Users in Drop-In Centers of Isfahan, Iran, International Journal of Preventive Medicine (2018)
7. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
8. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (44)
Nazila Kassaian (28)
Other Related Docs
9. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
10. Occult Hepatitis B Virus Infection Among Human Immunodeficiency Virus-Infected Patients With Isolated Hepatitis B Core Antibody in Isfahan, Iran, Journal of Research in Medical Sciences (2014)
11. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)
12. Risk Prison and Hepatitis B Virus Infection Among Inmates With History of Drug Injection in Isfahan, Iran, The Scientific World Journal (2013)
13. Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description, Journal of Isfahan Medical School (2011)
14. Effects of a Comprehensive Educational Program on Health Behaviors and Awareness of Hiv, Hepatitis B, and Hepatitis C in Men With Substance Use Disorders, Middle East Current Psychiatry (2024)
15. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
16. The Assessment of Hepatitis B Seroprevalence in Persons With Intravenous Drug Use History in the Isfahan Province: Community-Based Study, Journal of Research in Medical Sciences (2014)
17. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
18. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
19. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)
20. Prevalence of Hiv Infection in Individuals With History of Intravenous Drug Use Via Community Announcement in Isfahan-Iran, Pakistan Journal of Medical Sciences (2013)
21. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
22. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)
23. Prevalence of Hiv/Hcv/Hbv Infections and Drug-Related Risk Behaviours Amongst Idus Recruited Through Peer-Driven Sampling in Iran, International Journal of Drug Policy (2010)
24. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Among Young Prisoners, Journal of Research in Medical Sciences (2013)
25. Seroprevalence of Hepatitis B Virus Infection and Hepatitis B Surface Antibody Status Among Laboratory Health Care Workers in Isfahan, Iran, Asian Journal of Transfusion Science (2015)
26. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
27. Prevalence of Hiv Infection and Related Risk Factors in Isfahan Drop in Centers, Pakistan Journal of Medical Sciences (2013)
28. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
29. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
30. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
31. Occult Hepatitis B Virus Infection Among Blood Donors With Antibodies to Hepatitis B Core Antigen, Acta Medica Iranica (2008)
32. Hepatitis C Screening in Intravenous Drug Users Under Treatment With Methadone: An Action Reserch Study, Journal of Isfahan Medical School (2011)
33. Comparing the Effectiveness of a Short-Term Double-Dose Hepatitis B Vaccination Schedule With the Standard 3-Dose Schedule: A Randomized Clinical Trial, Tehran University Medical Journal (2011)
34. Analysis of the Related Factors in Hepatitis C Virus Infection Among Hemophilic Patients in Isfahan, Iran, Hepatitis Monthly (2007)
35. Hepatitis D Virus Infection in Isfahan, Central Iran: Prevalence and Risk Factors Among Chronic Hbv Infection Cases, Hepatitis Monthly (2011)
36. High Risky Behaviors Among Intravenous Drug Users in Isfahan, Iran: A Study for Hepatitis C Harm Reduction Programs, International Journal of Preventive Medicine (2012)
37. Occult Hepatitis B Among Iranian Hepatitis C Patients, Journal of Research in Medical Sciences (2009)
38. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
39. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
40. Comparison of Hbs-Antibody Serum Levels Between Patients With Type 2 Diabetes Mellitus and Controls Following Vaccination Against Hepatitis B, Journal of Isfahan Medical School (2007)
41. Prevalence of Latent Tuberculosis Infection and Hiv Among People Who Inject Drugs in Iran, Drug and Alcohol Review (2021)
42. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
43. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
44. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
45. Prevalence and Risk Factors of Hiv, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran, Hepatitis Monthly (2012)
46. Prevalence of Hiv Infection in Inmates With History of Injection Drug Use and Evaluation of Risk Factors, in Isfahan, Iran, Pakistan Journal of Medical Sciences (2013)
47. Hepatits C and B in Blood Transfusion Recipients Indentified at Isfahan Province, Journal of Isfahan Medical School (2011)
48. Evaluation of Healthcare Usage Rate in Hiv/Aids Patients in Isfahan, Iran in 2018, HIV and AIDS Review (2020)
49. Molecular Evaluation of Hepatitis E in Hiv Infected Patients in Isfahan, Iran, Tehran University Medical Journal (2018)
50. Hepatitis a Seropositivity Among Newly Admitted Medical Students of Isfahan, Kermanshah, and Hamedan: A Seroprevalence Study, Journal of Research in Medical Sciences (2014)